• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C5a-C5aR1轴在骨病理生理学中的作用:一篇综述

The role of C5a-C5aR1 axis in bone pathophysiology: A mini-review.

作者信息

Ruocco Anna, Sirico Anna, Novelli Rubina, Iannelli Silvia, Van Breda Shane Vontelin, Kyburz Diego, Hasler Paul, Aramini Andrea, Amendola Pier Giorgio

机构信息

R&D, Dompé Farmaceutici SpA, Naples, Italy.

R&D, Dompé Farmaceutici SpA, Milan, Italy.

出版信息

Front Cell Dev Biol. 2022 Aug 8;10:957800. doi: 10.3389/fcell.2022.957800. eCollection 2022.

DOI:10.3389/fcell.2022.957800
PMID:36003145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9393612/
Abstract

Bone remodeling is a physiological, dynamic process that mainly depends on the functions of 2 cell types: osteoblasts and osteoclasts. Emerging evidence suggests that complement system is crucially involved in the regulation of functions of these cells, especially during inflammatory states. In this context, complement component 5a (C5a), a powerful pro-inflammatory anaphylatoxin that binds the receptor C5aR1, is known to regulate osteoclast formation and osteoblast inflammatory responses, and has thus been proposed as potential therapeutic target for the treatment of inflammatory bone diseases. In this review, we will analyze the role of C5a-C5aR1 axis in bone physiology and pathophysiology, describing its involvement in the pathogenesis of some of the most frequent inflammatory bone diseases such as rheumatoid arthritis, and also in osteoporosis and bone cancer and metastasis. Moreover, we will examine C5aR1-based pharmacological approaches that are available and have been tested so far for the treatment of these conditions. Given the growing interest of the scientific community on osteoimmunology, and the scarcity of data regarding the role of C5a-C5aR1 axis in bone pathophysiology, we will highlight the importance of this axis in mediating the interactions between skeletal and immune systems and its potential use as a therapeutic target.

摘要

骨重塑是一个生理动态过程,主要依赖于两种细胞类型的功能:成骨细胞和破骨细胞。新出现的证据表明,补体系统在这些细胞功能的调节中起着关键作用,尤其是在炎症状态下。在这种情况下,补体成分5a(C5a)是一种强大的促炎过敏毒素,可与受体C5aR1结合,已知其可调节破骨细胞形成和成骨细胞炎症反应,因此已被提议作为治疗炎症性骨病的潜在治疗靶点。在本综述中,我们将分析C5a - C5aR1轴在骨生理和病理生理中的作用,描述其在一些最常见的炎症性骨病(如类风湿性关节炎)以及骨质疏松症、骨癌和转移的发病机制中的作用。此外,我们将研究目前可用的且已针对这些病症进行测试的基于C5aR1的药理学方法。鉴于科学界对骨免疫学的兴趣日益浓厚,以及关于C5a - C5aR1轴在骨病理生理学中作用的数据稀缺,我们将强调该轴在介导骨骼与免疫系统相互作用中的重要性及其作为治疗靶点的潜在用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5425/9393612/813c0b9bf804/fcell-10-957800-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5425/9393612/33c39114ab75/fcell-10-957800-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5425/9393612/813c0b9bf804/fcell-10-957800-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5425/9393612/33c39114ab75/fcell-10-957800-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5425/9393612/813c0b9bf804/fcell-10-957800-g002.jpg

相似文献

1
The role of C5a-C5aR1 axis in bone pathophysiology: A mini-review.C5a-C5aR1轴在骨病理生理学中的作用:一篇综述
Front Cell Dev Biol. 2022 Aug 8;10:957800. doi: 10.3389/fcell.2022.957800. eCollection 2022.
2
C5aR1 interacts with TLR2 in osteoblasts and stimulates the osteoclast-inducing chemokine CXCL10.C5aR1 在成骨细胞中与 TLR2 相互作用,并刺激破骨细胞诱导趋化因子 CXCL10。
J Cell Mol Med. 2018 Dec;22(12):6002-6014. doi: 10.1111/jcmm.13873. Epub 2018 Sep 24.
3
Complement receptor C5aR1 on osteoblasts regulates osteoclastogenesis in experimental postmenopausal osteoporosis.成骨细胞上的补体受体 C5aR1 调节实验性绝经后骨质疏松症中的破骨细胞生成。
Front Endocrinol (Lausanne). 2022 Sep 30;13:1016057. doi: 10.3389/fendo.2022.1016057. eCollection 2022.
4
Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing.成骨细胞特异性过表达补体受体C5aR1会损害骨折愈合。
PLoS One. 2017 Jun 14;12(6):e0179512. doi: 10.1371/journal.pone.0179512. eCollection 2017.
5
Inhibition of C5AR1 impairs osteoclast mobilization and prevents bone loss.抑制 C5AR1 可损害破骨细胞的动员并防止骨质流失。
Mol Ther. 2023 Aug 2;31(8):2507-2523. doi: 10.1016/j.ymthe.2023.04.022. Epub 2023 May 4.
6
Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.阻断补体 C5a/C5aR1 轴通过 CXCL16 介导的作用损害肺癌骨转移。
Am J Respir Crit Care Med. 2018 May 1;197(9):1164-1176. doi: 10.1164/rccm.201703-0660OC.
7
Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients.补体 C5a 诱导严重创伤患者促炎微囊泡释放。
Front Immunol. 2020 Sep 2;11:1789. doi: 10.3389/fimmu.2020.01789. eCollection 2020.
8
Complement C5a Receptor 1 Exacerbates the Pathophysiology of Sepsis and Is a Potential Target for Disease Treatment.补体 C5a 受体 1 加重脓毒症的病理生理学改变,是疾病治疗的潜在靶点。
mBio. 2018 Jan 23;9(1):e01755-17. doi: 10.1128/mBio.01755-17.
9
The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.C5a 在中性粒细胞介导的关节和皮肤自身免疫性炎症中的起始作用至关重要。
Semin Immunol. 2018 Jun;37:21-29. doi: 10.1016/j.smim.2018.03.002. Epub 2018 Mar 27.
10
C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.C5a/C5aR1 通路在银屑病发病机制中起关键作用。
Front Immunol. 2019 Aug 7;10:1866. doi: 10.3389/fimmu.2019.01866. eCollection 2019.

引用本文的文献

1
To investigate the mechanism of Yiwei Decoction in the treatment of premature ovarian insufficiency-related osteoporosis using transcriptomics, network pharmacology and molecular docking techniques.采用转录组学、网络药理学和分子对接技术探讨益维汤治疗卵巢早衰相关骨质疏松症的作用机制。
Sci Rep. 2023 Nov 3;13(1):19016. doi: 10.1038/s41598-023-45699-8.
2
Structural biology of complement receptors.补体受体的结构生物学。
Front Immunol. 2023 Sep 11;14:1239146. doi: 10.3389/fimmu.2023.1239146. eCollection 2023.

本文引用的文献

1
The C5a/C5aR1 Axis Contributes to the Pathogenesis of Acute Cystitis Through Enhancement of Adhesion and Colonization of Uropathogenic .C5a/C5aR1轴通过增强尿路致病性细菌的黏附和定植促进急性膀胱炎的发病机制。
Front Cell Infect Microbiol. 2022 Mar 30;12:824505. doi: 10.3389/fcimb.2022.824505. eCollection 2022.
2
Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis.阿伐考潘,一种选择性 C5a 受体拮抗剂,用于治疗抗中性粒细胞胞质抗体相关性血管炎。
Mod Rheumatol. 2022 Apr 18;32(3):475-483. doi: 10.1093/mr/roab104.
3
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.
补体C5a通过髓源性抑制细胞诱导中性粒细胞胞外陷阱的形成以促进转移。
Cancer Lett. 2022 Mar 31;529:70-84. doi: 10.1016/j.canlet.2021.12.027. Epub 2021 Dec 28.
4
Emerging Role of C5 Complement Pathway in Peripheral Neuropathies: Current Treatments and Future Perspectives.C5补体途径在周围神经病变中的新作用:当前治疗方法与未来展望
Biomedicines. 2021 Apr 7;9(4):399. doi: 10.3390/biomedicines9040399.
5
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis.除关节外,类风湿关节炎的关节外表现。
Autoimmun Rev. 2021 Feb;20(2):102735. doi: 10.1016/j.autrev.2020.102735. Epub 2020 Dec 17.
6
Flare-up of cytokines in rheumatoid arthritis and their role in triggering depression: Shared common function and their possible applications in treatment (Review).类风湿关节炎中细胞因子的爆发及其在引发抑郁中的作用:共同功能及其在治疗中的可能应用(综述)
Biomed Rep. 2021 Jan;14(1):16. doi: 10.3892/br.2020.1392. Epub 2020 Nov 19.
7
Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis.中性粒细胞介导的氨甲酰化促进类风湿关节炎的关节损伤。
Sci Adv. 2020 Oct 28;6(44). doi: 10.1126/sciadv.abd2688. Print 2020 Oct.
8
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.COVID-19 炎症与 C5a-C5aR1 轴的激活有关。
Nature. 2020 Dec;588(7836):146-150. doi: 10.1038/s41586-020-2600-6. Epub 2020 Jul 29.
9
Neutrophil extracellular traps mediate articular cartilage damage and enhance cartilage component immunogenicity in rheumatoid arthritis.中性粒细胞胞外诱捕网介导类风湿关节炎关节软骨损伤并增强软骨成分免疫原性。
JCI Insight. 2020 Jul 9;5(13):139388. doi: 10.1172/jci.insight.139388.
10
Inhibition of osteoclast activity by complement regulation with DF3016A, a novel small-molecular-weight C5aR inhibitor.通过新型小分子 C5aR 抑制剂 DF3016A 抑制破骨细胞活性的补体调控作用。
Biomed Pharmacother. 2020 Mar;123:109764. doi: 10.1016/j.biopha.2019.109764. Epub 2019 Dec 31.